Original Article |
Corresponding author: Rerdin Julario ( dr.rerdinjulario@gmail.com ) © 2022 Eka Prasetya Budi Mulia, Kartika Afrida Fauzia, Rerdin Julario.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Mulia EPB, Fauzia KA, Julario R (2022) High risk of ventricular repolarization abnormalities among hemodialytic end-stage renal disease patients. Folia Medica 64(6): 905-912. https://doi.org/10.3897/folmed.64.e68349
|
Introduction: Patients with chronic renal disease (CKD) are at a significantly elevated risk for ventricular arrhythmia. Several electrocardiographic (ECG) methods can be used to assess the ventricular arrhythmia risk on the standard 12-lead ECG.
Aim: This study aimed to evaluate the ECG parameters of ventricular repolarization abnormalities, such as QT, QTc, Tp-e, and Tp-e/QT ratio, Tp-e/QTc ratio, and their predictors in hemodialytic end-stage renal disease (ESRD) patients.
Materials and methods: Fifty-three patients with hemodialytic ESRD and 32 pre-dialytic CKD patients were enrolled in the study. ECG parameters were measured manually using calipers. The independent samples t-test was used for comparative analysis. The multivariate linear regression analysis was used to distinguish the independent predictors of each ECG parameters and variables correlating significantly in bivariate analysis.
Results: Mean ages of hemodialytics and pre-dialytics were 47±11 and 51±7 years, respectively. Ventricular repolarization abnormalities in the hemodialytic compared to the pre-dialytic group were found to be significantly different [QTc (448±34 vs. 428±31 ms, p=0.007), Tp-e (81±20 vs. 71±19 ms, p=0.025), Tp-e/QT (0.23±0.06 vs. 0.20±0.05, p=0.043)]. QTc interval was positively correlated with sodium (p=0.001) and age (p=0.007). Tp-e/QT ratio was the ECG parameter correlated to most of variables including eGFR (p=0.003), creatinine (p=0.040), potassium (p=0.009), chloride (p=0.048), and glucose (p=0.041).
Conclusions: Ventricular repolarization was found to be increased in patients with hemodialytic ESRD. Hence, observation ECG parameters of ventricular repolarization should be performed in the hemodialytic patients for early detection of ventricular arrhythmia.
electrocardiography, end-stage renal disease, ventricular repolarization, QTc interval
Chronic kidney disease (CKD) is a significant health problem across the world. Estimated global CKD prevalence is consistent between 11% and 13%, with most of them being stage 3.[
The incidence of ventricular arrhythmia that can be cardiac mortality marker was high in the ESRD patients and increasing at the end of hemodialysis.[
Ventricular repolarization is a critical process in which the associated abnormalities are related to a higher risk of ventricular arrhythmias.[
This study aimed to evaluate the ECG parameters of ventricular repolarization abnormalities such as QT, QTc, Tp-e, and Tp-e/QT ratio, Tp-e/QTc ratio in patients with hemodialytic ESRD.
This prospective case-control study was carried out at the Internal Medicine Ward in one of the third-level referral hospitals for East Indonesia region. The study was conducted over a three-month period from January to March 2020. All participants gave their informed consents. The hospital’s Ethics Committee approved the study procedure.
Fifty-three patients (27 men and 26 women) with regular hemodialytic ESRD and thirty-two (21 men and 11 women) pre-dialytic patients as controls were enrolled consecutively in the study. All patients between the ages of 15–90 years were included in this study. Hemodialysis was performed twice weekly with volumetrically controlled machines (Surdial 55 Plus, Nipro, Japan). Bicarbonate dialysate was used and adjusted according to individual sodium requirements. Patients who required anticoagulant therapy received systemic unfractionated heparin. Patients taking antiarrhythmic drugs that prolong the QT interval, having ECG of right or left bundle branch block, acute coronary syndromes (chronic coronary syndrome more than six months was included), structural heart disease, diagnosed with active infection, acute stroke, malignant or benign hematologic disorders, right- or left-sided heart failure (systolic heart failure, heart failure with reduced ejection fraction), and cancer, and patients who received surgery in the past six months were excluded. ESRD was defined by following the classification of Kidney Foundation Disease Outcomes Quality Initiative, based on estimated glomerular filtration rate (eGFR) with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. Hemodialytic patients determined if they regularly received hemodialysis while pre-dialytic CKD patients have never received hemodialysis and were not indicated to have hemodialysis. In the hemodialytic group, the data from the laboratory blood examination such as the concentrations of potassium, sodium, chloride, creatinine, blood urea nitrogen (BUN), plasma glucose, albumin, and hemoglobin were obtained within 6 hours before hemodialysis procedure.
ECG (GE Mac 1600) with twelve leads surface was performed on every patient at the same time of blood sampling, and the printed result was analyzed. By using calipers, QT interval was measured from the earliest onset of the Q wave to the end of the T wave in all leads, and the longest value was used. If a U wave was observed, an alternate lead was chosen, or a tangent was drawn from the downslope of the T wave at its steepest part until it crossed the TP segment. QTc was calculated by the Bazett formula (QTc = QT/√RR). T-peak to T-end (Tp-e) was calculated in the leads with the longest QT interval as the duration from the peak of the T wave to the end of the T wave. Calculation of the Tp-e/QT and Tp-e/QTc ratio was done by dividing Tp-e by QT or QTc.
The statistical analysis of the data was carried out with SPSS v.25 (IBM Corp., Armonk, N.Y., USA). The Shapiro-Wilk test was used to analyze the normality of data. Continuous data of variables with normal and deviation from normal distribution were described as mean ± standard deviation (SD) and median (interquartile range [IQR]), respectively. The independent t-test or Mann-Whitney test for normal and non-normal data distribution was used in the comparative analysis of two independent groups. Nominal data were expressed as numbers and percentages. The χ2 test was used for nominal data comparison. Pearson and Spearman correlation tests were used for bivariate correlation analysis. Within the hemodialytic group, variables in the bivariate analysis with p<0.05 were included in the multivariate analysis using linear regression with stepwise method to distinguish the independent predictors of each ECG parameters. A p-value <0.05 was accepted as statistically significant.
Fifty-three patients (27 men and 26 women) with regular hemodialytic ESRD and thirty-two (21 men and 11 women) pre-dialytic CKD (stage 2-4) as controls were enrolled in the study. The mean ages were not different between the hemodialytic and pre-dialytic groups, which were 47±11 and 51±7 years, respectively. There was no difference in the distribution of age and sex between the two groups.
The hemodialytic patients were a special group with several significantly different characteristics, even when compared to the pre-dialytic patients as summarized in Table
Compared to controls, laboratory parameters showed that BUN (p<0.001) and creatinine (p<0.001) were higher, while eGFR (p<0.001) and hemoglobin (p<0.001) were lower in the hemodialysis group. Concordant with the DM diagnosis, the blood glucose level was also lower in the hemodialytic patient. While for electrolytes (sodium, potassium, chloride) and albumin, there were no significant differences between the hemodialytic and control groups.
Characteristics | Hemodialytic patients (n=53) | Pre-dialytic controls (n=32) | P-value |
Age (year) | 47±12 | 51±7 | 0.066 |
Sex (men/women) | 27/26 | 21/11 | 0.186 |
DM, n (%) | 11 (20.8%) | 20 (62.5%) | <0.001 |
HTN, n (%) | 34 (64.2%) | 12 (37.5%) | 0.017 |
eGFR (mL/min) | 4.9 (4.2:22.1) | 23.7 (20.8:35.5) | <0.001 |
BUN (mg/dL) | 66.2±31.0 | 37.1±17.4 | <0.001 |
Creatinine (mg/dL) | 10.1±4.5 | 2.4±0.7 | <0.001 |
Sodium (mEq/L) | 133.4±6.2 | 131.3±7.5 | 0.179 |
Potassium (mEq/L) | 4.4±0.9 | 4.5±1.0 | 0.552 |
Chloride (mEq/L) | 99.5±6.7 | 98.8±8.1 | 0.661 |
Albumin (g/dL) | 3.4±0.8 | 3.1±0.6 | 0.149 |
Hemoglobin (g/dL) | 7.0±1.8 | 10.1±2.1 | <0.001 |
Plasma glucose (mg/dL) | 120 (100:213) | 186 (105:287) | 0.005 |
ECG analysis revealed that all (100%) hemodialytic patients and controls had normal sinus rhythm. Three patients (3.7%) in the hemodialytic group had first degree AV block. One patient (3.1%) in the control group had a second-degree type 1 AV block. Premature ventricular contractions were found in hemodialytic and control group, which were one (1.9%) and two patients (6.3%), respectively.
Focusing on the ventricular abnormality, the ECG parameters listed in Table
ECG parameters | Hemodialytic patients (n=53) | Pre-dialytic controls (n=32) | P-value |
HR (bpm) | 96±18 | 89±16 | 0.071 |
QT (ms) | 360±48 | 356±37 | 0.646 |
QTc (ms) | 448±34 | 428±31 | 0.007 |
Tp-e (ms) | 81±20 | 71±19 | 0.025 |
Tp-e/QT | 0.23±0.06 | 0.20±0.05 | 0.043 |
TP-e/QTc | 0.18±0.05 | 0.17±0.04 | 0.145 |
The variables of age, sex, DM, HTN, eGFR, BUN, creatinine, sodium, potassium, chloride, albumin, hemoglobin, and plasma glucose of the hemodialytic patients were analyzed along with each of the ECG parameters. No relationship was found between the ECG parameters and any of the following variables: sex, DM, HTN, BUN, and hemoglobin. As shown in Supplementary Table
Various laboratory parameters within hemodialytic patients were analyzed using multivariate linear regression, as shown in Table
Multivariate linear regression analysis between various study variables and ECG parameters in hemodialytic patients
Factors | β (95% CI) | P | R square | |
QT | Sodium (mEq/L) | 2.086 (0.105, 4.068) | 0.039 | 0.194 |
Albumin (g/dL) | 18.301 (2.576, 34.027) | 0.023 | ||
QTc | Age (years) | −0.946 (−1.688, −0.205) | 0.013 | 0.235 |
Sodium (mEq/L) | 1.736 (0.371, 3.100) | 0.014 | ||
Tp-e | Potassium (mEq/L) | −9.747 (−15.543, −3.951) | 0.001 | 0.183 |
Tp-e/QTc | Potassium (mEq/L) | −0.022 (−0.035 to −0.009) | 0.011 | 0.184 |
Decreasing kidney function was correlated with increased risk of CVD due to high inflammation reaction and prothrombotic factors, low hemoglobin levels, albuminuria, and abnormal bone and mineral metabolism. Evaluation of ECG ventricular repolarization abnormalities to deal with the potential risk of fatal arrhythmias, including SCD, can provide useful clinical information especially for the hemodialytic ESRD population.[
It is important to determine factors related to ventricular abnormalities in ESRD patients. Previous studies were performed in the United States or with European population while studies on Indonesian population were scarce.[4,8,13,
Several parameters for ventricular repolarization abnormalities have been determined by many studies, such as QT, QTc, Tp-e, Tp-e/QT ratio, and Tp-e/QTc. The QT interval reflects the depolarization and ventricular repolarization dispersion. Prolongation of QT (or QTc) interval indicates a potential risk of ventricular arrhythmias, SCD, and even one of the causes of mortality related to a cardiovascular event in South East Asian population.[
In this study, QTc interval in hemodialytic group was found to be significantly higher compared to pre-dialytic group (p=0.007). Our result was in accordance with some previous studies which found that QT, QTc, and QTc dispersion were increased in dialysis patients compared to controls.[
Our study demonstrated that several factors correlated and may predict the prolongation of QT. Alteration of electrolyte control in the ESRD patients and regulation by hemodialytic procedure may cause an electrolyte imbalance that could affect the cardiac function. Hence, we observed the patient’s electrolytes levels. The increase of sodium (p=0.039) and albumin level (p=0.023) were the independent predictors of the increased QT interval. Sodium level (p=0.014) and age (p=0.013) were also the independent predictors of an increased QTc interval. These results were concordant with the observation of Jaroszynski et al. that showed alterations of serum potassium, phosphorus, calcium, and extracellular volume during hemodialysis may affect QTc dispersion and advance ventricular arrhythmogenesis.[
Interestingly, a negative correlation of age with the QTc value was observed in the hemodialytic patients; older patients had a lower QTc interval. This result was also consistent in the multivariate analysis. Our observation showed a contrary result with the normal population that showed an increasing QTc in older ages. However, the mechanisms were unknown, and further study with larger samples may be necessary. Diabetes also has possible association with prolonged QTc as a cause of ESRD. We should bear in mind that patients undergoing hemodialysis can become hypoglycemic without realizing it.[
The Tp-e interval (p=0.025) and Tp-e/QT ratio (p=0.043) were found to be higher in the hemodialytic ESRD group compared to controls in our study. A study by Kollu et al. also showed that the Tp-e/QT ratio was higher in CKD stages 3–5 patients on no Renal Replacement Therapy compared to the healthy subjects.[
Several limitations can be found in our study. First, this was a single-center study with a relatively small sample size in one measurement. The effect of serum electrolytes on changes in cardiac repolarization can ideally be compared with ECG after rapid transmembrane electrolyte changes. Other confounding factors such as the time from beginning dialysis to the present study could not be obtained. Further risk factors for ventricular repolarization abnormalities were not taken into account for the analysis. Due to the not routine part of blood tests conducted at the hospital, serum magnesium was not measured in all patients, including controls, but we assume serum magnesium will increase as CKD develops. In addition, blood PH and calcium could not be measured in both groups for technical reasons. We also did not evaluate the relationship between arrhythmia incident and the ventricular abnormalities parameters.
The parameters for ventricular repolarization abnormalities in hemodialytic patients represented by QTc, Tp-e, and Tp-e/QT were significantly different compared to those of the predialytic group. Different independent factors within hemodialytic patients were found for each parameter, but the most important independent factors were sodium, albumin, and potassium. Hence, observation of QT, QTc, Tp-e, Tp-e/QT, and Tp-e/QTc should be performed in hemodialysis patients, especially with the high sodium, albumin, and potassium level for early detection of ventricular arrhythmia and prevention of SCD.
Bivariate analysis result of various study variables and ECG parameters in hemodialytic patients
Variables n = 53 | QT | QTc | Tp-e | Tp-e/QT | Tp-e/QTc | |||||
r | p | r | p | r | p | r | p | r | p | |
Age (years) | −0.119 | 0.395 | −0.367 | 0.007 | −0.030 | 0.833 | −0.065 | 0.646 | −0.136 | 0.333 |
Sex (Men) | - | 0.582* | - | 0.774* | - | 0.251** | - | 0.136* | - | 0.185* |
Diabetes mellitus | - | 0.351* | - | 0.341* | - | 0.432** | - | 0.466* | - | 0.451* |
Hypertension | - | 0.146* | - | 0.803* | - | 0.267** | - | 0.130* | - | 0.333* |
eGFR (mL/min) | −0.163 | 0.243 | −0.140 | 0.317 | 0.261 | 0.059 | 0.294 | 0.033 | 0.316 | 0.021 |
BUN (mg/dL) | 0.071 | 0.614 | 0.144 | 0.305 | −0.193 | 0.166 | −0.211 | 0.130 | −0.239 | 0.085 |
Creatinine (mg/dL) | 0.177 | 0.205 | 0.174 | 0.212 | −0.221 | 0.112 | −0.283 | 0.040 | −0.275 | 0.046 |
Sodium (mEq/L) | 0.422 | 0.002 | 0.455 | 0.001 | −0.015 | 0.918 | −0.210 | 0.131 | −0.168 | 0.228 |
Potassium (mEq/L) | −0.139 | 0.322 | −0.019 | 0.894 | −0.426 | 0.001 | −0.357 | 0.009 | −0.434 | 0.001 |
Chloride (mEq/L) | 0.230 | 0.098 | 0.102 | 0.469 | −0.149 | 0.286 | −0.273 | 0.048 | −0.190 | 0.172 |
Albumin (g/dL) | 0.391 | 0.004 | 0.123 | 0.379 | 0.110 | 0.432 | −0.069 | 0.624 | 0.081 | 0.567 |
Hemoglobin (g/dL) | −0.237 | 0.088 | −0.072 | 0.609 | −0.255 | 0.065 | −0.151 | 0.280 | −0.239 | 0.085 |
Glucose (mg/dL) | −0.221 | 0.112 | −0.071 | 0.611 | 0.235 | 0.091 | 0.281 | 0.041 | 0.236 | 0.088 |
This research proposal was approved by the ethical committees of Dr. Soetomo General Academic Hospital (Ref: 1811/KEPK/II/2020; February 2, 2020). A written informed consent was obtained from all patients.
No animals were used in this research. All human research procedures were followed in accordance with the ethical standards of the committee responsible for human experimentation (institutional), and with the Helsinki Declaration of 1975, as revised in 2013.
The datasets generated during and/or analyzed during the current study are not publicly available due to protecting participant confidentiality but are available from the corresponding author on reasonable request.
No funding was received for the production of this ma- nuscript.
The authors report no conflicts of interest.